Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
BioMarin Pharmaceutical Inc. Stock Price (Quote) NASDAQ:BMRN
$79.72 ( 0.55% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $73.93 | $84.66 | Friday, 20th May 2022 BMRN stock ended at $79.72. This is 0.55% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 3.22% from a day low at $78.26 to a day high of $80.78. |
| 90 days | $72.00 | $86.90 | |
| 52 weeks | $71.59 | $94.20 |
Historical BioMarin Pharmaceutical Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $79.76 | $80.78 | $78.26 | $79.72 | 1 114 144 |
| 2022-05-19 | $78.40 | $80.36 | $78.12 | $79.28 | 852 209 |
| 2022-05-18 | $78.30 | $79.99 | $77.61 | $78.18 | 936 708 |
| 2022-05-17 | $77.61 | $79.34 | $77.59 | $79.12 | 1 069 360 |
| 2022-05-16 | $77.65 | $78.17 | $76.41 | $77.32 | 1 082 939 |
| 2022-05-13 | $77.30 | $78.90 | $76.90 | $77.73 | 1 820 135 |
| 2022-05-12 | $75.12 | $76.47 | $74.30 | $76.38 | 1 617 879 |
| 2022-05-11 | $78.56 | $79.57 | $75.60 | $75.68 | 1 620 560 |
| 2022-05-10 | $76.44 | $80.23 | $76.00 | $79.43 | 1 697 037 |
| 2022-05-09 | $78.00 | $78.48 | $73.93 | $74.62 | 1 826 336 |
| 2022-05-06 | $81.00 | $81.87 | $78.96 | $79.26 | 848 981 |
| 2022-05-05 | $84.14 | $84.30 | $81.12 | $81.97 | 827 501 |
| 2022-05-04 | $83.82 | $84.66 | $81.31 | $84.65 | 884 608 |
| 2022-05-03 | $83.13 | $84.03 | $82.28 | $83.52 | 1 341 160 |
| 2022-05-02 | $80.38 | $83.47 | $80.36 | $83.31 | 1 220 566 |
| 2022-04-29 | $81.95 | $83.61 | $81.12 | $81.35 | 1 481 155 |
| 2022-04-28 | $83.79 | $84.29 | $78.95 | $82.64 | 2 225 071 |
| 2022-04-27 | $79.94 | $81.15 | $79.50 | $80.31 | 1 121 963 |
| 2022-04-26 | $80.97 | $81.95 | $79.28 | $79.29 | 926 766 |
| 2022-04-25 | $82.18 | $82.74 | $80.74 | $81.88 | 1 105 124 |
| 2022-04-22 | $81.20 | $81.20 | $79.97 | $80.49 | 391 383 |
| 2022-04-21 | $81.20 | $82.09 | $80.05 | $80.50 | 805 500 |
| 2022-04-20 | $80.52 | $81.42 | $79.67 | $80.61 | 1 244 800 |
| 2022-04-19 | $81.61 | $82.19 | $80.47 | $80.58 | 1 068 700 |
| 2022-04-18 | $81.91 | $82.14 | $80.49 | $81.18 | 992 900 |
| 2022-04-14 | $83.66 | $84.67 | $82.89 | $82.95 | 534 953 |
| 2022-04-13 | $82.47 | $84.39 | $82.45 | $84.00 | 733 152 |
| 2022-04-12 | $83.89 | $84.36 | $82.29 | $82.56 | 605 593 |
| 2022-04-11 | $85.71 | $86.54 | $83.24 | $83.27 | 963 163 |
| 2022-04-08 | $83.33 | $86.59 | $83.08 | $86.04 | 1 739 000 |
| 2022-04-07 | $79.92 | $84.12 | $79.92 | $83.35 | 1 438 400 |
| 2022-04-06 | $78.74 | $80.53 | $78.46 | $80.16 | 602 300 |
| 2022-04-05 | $80.00 | $81.85 | $79.34 | $79.45 | 1 015 000 |
| 2022-04-04 | $79.71 | $81.13 | $79.55 | $80.28 | 1 094 000 |
| 2022-04-01 | $77.18 | $79.70 | $76.76 | $79.27 | 2 514 279 |
| 2022-03-31 | $78.33 | $78.67 | $76.80 | $77.09 | 2 542 066 |
| 2022-03-30 | $79.56 | $80.99 | $77.53 | $77.89 | 1 083 951 |
| 2022-03-29 | $79.43 | $80.16 | $78.81 | $79.56 | 1 198 200 |
| 2022-03-28 | $79.21 | $79.73 | $77.83 | $78.36 | 966 600 |
| 2022-03-25 | $80.61 | $80.99 | $78.88 | $79.02 | 628 400 |
| 2022-03-24 | $80.90 | $81.51 | $80.31 | $80.88 | 531 300 |
| 2022-03-23 | $81.78 | $82.37 | $80.69 | $80.86 | 869 800 |
| 2022-03-22 | $81.00 | $82.57 | $79.29 | $82.15 | 992 828 |
| 2022-03-21 | $81.29 | $82.29 | $80.74 | $81.16 | 612 994 |
| 2022-03-18 | $80.12 | $81.92 | $80.09 | $81.67 | 980 057 |
| 2022-03-17 | $80.30 | $81.66 | $77.97 | $80.28 | 1 458 300 |
| 2022-03-16 | $79.11 | $80.76 | $77.98 | $80.72 | 1 072 500 |
| 2022-03-15 | $75.96 | $78.27 | $75.00 | $78.27 | 1 041 700 |
| 2022-03-14 | $76.19 | $77.31 | $75.19 | $76.01 | 782 300 |
| 2022-03-11 | $77.81 | $78.06 | $75.88 | $75.98 | 842 800 |
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Kuvan, a proprietary syn... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
